top of page

Ketamine Infusions and Rapid Reduction of Suicidal and Depressive Symptoms in Major Depressive Episode: A Systematic Review and Meta-Analysis

Jun 12
1 min read

key takeaway: "This systematic review and meta-analysis of 26 randomized clinical trials with 1166 patients with an MDE found that ketamine was efficacious in reducing suicidal and depressive symptoms rapidly, within hours. Reported serious adverse events (eg, deaths) were unrelated to the interventions, and other adverse events (eg, headache) were transient and resolved during the trials."


Recent Posts

See All
Suicide Rates by Gender Among 10- to 14-Year-Olds

Suicide Rates by Gender Among 10- to 14-Year-Olds, in JAMA Pediatrics key takeaway: "Suicide rates increased markedly in this age group between 2007 and 2021. Historically, suicide rates have been hig

 
 
 

Comments

bottom of page